Crossover in Adjuvant Trastuzumab Trials: Sparing Toxicity in Patient Care

*Departments of Epidemiology and Biostatistics

‡Medicine, University of California San Francisco, San Francisco, CA

†Department of Oncology, Geneva University Hospital, Geneva, Switzerland

J.E.T.: provision of study material, collection of data, data analysis and interpretation, manuscript writing. T.O.: design of the study, provision of study material, data analysis and interpretation, manuscript writing. V.K.P.: conception of the study, manuscript writing, final approval of manuscript.

Supported by Arnold Ventures.

V.K.P. royalties from Johns Hopkins Press, Medscape, and MedPage; consulting fees from UnitedHealthcare and OptumRx; and subscriber fees from Patreon, YouTube, and Substack. The other authors declare no conflicts of interest.

Correspondence: Vinay K. Prasad, MD, MPH, Department of Epidemiology and Biostatistics, University of California, San Francisco, 550 16th Street, 2nd Floor, San Francisco, CA 94158. E-mail: [email protected].

留言 (0)

沒有登入
gif